Abstract
Little is known of the functions of caspases in mediating the surface changes required for phagocytosis of dying cells. Here we investigate the role played by the effector caspase, caspase-3 in this process using the caspase-3-defective MCF-7 breast carcinoma line and derived caspase-3-expressing transfectants. Our results indicate that, while certain typical features of apoptosis induced by etoposide – namely classical morphological changes and the ability to degrade DNA into oligonucleosomal fragments – are caspase-3-dependent, loss of cell adhesion to plastic and the capacity to interact with, and to be phagocytosed by, human monocyte-derived macrophages – both by CD14-dependent and CD14-independent mechanisms – do not require caspase-3. Furthermore, both etoposide-induced caspase-3-positive and -negative MCF-7 cells suppressed proinflammatory cytokine release by macrophages. These results demonstrate directly that cell surface changes that are sufficient for anti-inflammatory clearance by human macrophages can be regulated independently of stereotypical features of the apoptosis programme that require caspase-3.
Similar content being viewed by others
Introduction
The final stage in the apoptosis programme is the phagocytosis of the dead and dying cells and their membrane-bound fragments.1,2 At body surfaces, apoptotic cells can be lost to the external environment, while elsewhere they are phagocytosed either by amateur phagocytic neighbours, or by macrophages, the professional phagocytes. Apoptotic cells fail to elicit proinflammatory responses and can exert anti-inflammatory effects on macrophages as evidenced by their release of soluble anti-inflammatory mediators, TGF-β1, PGE2 and PAF, in response to apoptotic cells.3 Since the persistence of apoptotic cells can have detrimental consequences such as inflammation and autoimmune disease, their efficient phagocytosis is of significant biological value.
The molecular mechanisms that underlie the recognition and phagocytosis of apoptotic cells by macrophages are not clear. Little is yet known of the changes at cell surfaces that are induced by the apoptosis programme to support apoptotic-cell clearance apart from the loss of plasma-membrane phospholipid asymmetry illustrated by the externalisation of phosphatidylserine (PS), which is normally resident in the inner leaflet of the plasma membrane.4,5,6 Other, as yet ill-defined, cell-surface changes that support apoptotic-cell/macrophage interactions include alterations in surface carbohydrates7,8 and qualitative changes in the intercellular adhesion molecule (ICAM)-3 on apoptotic leukocytes.9 On the side of the macrophage, a growing body of evidence indicates that a variety of receptors of diverse structure are involved in apoptotic-cell removal. These include (i) CD14,10 (ii) a novel PS-receptor,11 (iii) the integrin αvβ3,12,13 (iv) CD36,13,14 (v) the class A scavenger receptor SR-A,15 (vi) the ATP-binding cassette transporter, ABC-1,16,17 (vii) the receptor tyrosine kinase, MER18 and (viii) the α-2-macroglobulin receptor, CD91.19Additional molecules, notably thrombospondin,13 Clq,19,20 mannose-binding lectin, calreticulin19 and C-reactive protein21 may serve as intermediates that bridge macrophage and apoptotic-cell surfaces or act as opsonins. The relative importance of each of these molecules has not yet been clearly established, although mice defective in ABC-1,17 MER18 and Clq20 have defective apoptotic-cell clearance phenotypes, with MER- and Clq-deficient animals more prone to development of autoimmunity and autoimmune disease.18,20 In addition, recognition of PS by the PS-receptor appears to be essential for engulfment to proceed.11,22 Intriguingly, recent genetic studies of Caenorhabditis elegans indicate that phagocytic events can themselves promote cell death.23,24
The apoptosis programme is a genetically controlled, cell-autonomous programme that probably exists in dormant form in all mammalian somatic cells. It is now widely accepted that several members of the caspase family of proteases play key roles in inducing and executing apoptosis.25,26 However, little is yet known of the requirement for these proteases in causing the changes on apoptotic-cell surfaces that are necessary for recognition and phagocytosis. One caspase in particular, caspase-3 – which is known to cleave over 40 substrates containing DxxD motifs during apoptosis 26 – appears critical in producing some of the most striking stereotypical features of apoptosis. Significantly, caspase-3-defective cells fail to display either the typical morphological features of apoptosis – including chromatin condensation and nuclear fragmentation – that were used originally to define the process,27 or the prototypical biochemical hallmark of apoptosis, the organised degradation of DNA into oligonucleosomal fragments.28,29 In this work, we investigate the role played by caspase-3 in orchestrating the changes that are required for cell engulfment by macrophages. Here we demonstrate directly that the biochemical mechanisms that cause the classical morphological features of apoptosis can be uncoupled from those that allow non-phlogistic interaction with macrophages. These findings indicate that different facets of the execution phase of the apoptosis programme are independently regulated and suggest that therapeutic strategies aimed at suppressing caspase-3 activity may require complementary measures that inhibit cell clearance by phagocytes.
Results
Derivation of caspase-3-expressing MCF-7 cells
The MCF-7 breast carcinoma line was chosen for these studies since it is known to be defective in caspase-3 expression.28,34 Using the pEGFP-N1 expression vector, stable MCF-7 transfectants were derived with either GFP alone or a caspase-3-GFP (C-terminal) fusion protein. These transfectants were called MCF-7-N1 and MCF-7-C3, respectively (Figure 1a). GFP facilitated derivation of stable transfectants by cell sorting, permitted routine monitoring of caspase-3 levels by flow cytometry (Figure 1a) and could be used to monitor plasma-membrane integrity (see Figure 4). Caspase-3-expression in MCF-7-C3 cells was confirmed by immunoblotting, which demonstrated the 59 kDa band of the caspase-3-GFP fusion protein (Figure 1b). No caspase-3 was detectable in either the MCF-7 parental line or in the MCF-7-N1 GFP transfectants.
Caspase-3 activation accelerates, but is dispensable for, genotoxic death of MCF-7 cells
MCF-7 cells contain wild-type p53 and grow as a monolayer. Exposure to a genotoxic stimulus induces detachment from the monolayer and death. We compared the rate of detachment of MCF-7-N1 and MCF-7-C3 cells following treatment with the topoisomerase II inhibitor, etoposide. As shown in Figure 2a, the presence of caspase-3 accelerated detachment of MCF-7 cells from the monolayer, but was not a prerequisite for detachment. To assess caspase-3 activation in the etoposide-treated MCF-7-C3 cells, immunoblots of lysates of the detached, floating cells were compared with those of the adherent cells using an antibody to the large fragment of caspase-3. As shown in Figure 2b, the appearance of bands of 19/20 kDa in the floating fractions of etoposide-treated cells indicated that caspase-3 was activated in the detached cells. Active caspase-3 was also detectable at times in the adherent fraction, although to a much lesser degree than in the floating fraction (see for example, the weak 19 kDa band in the 48 h adherent sample in Figure 2b). These results suggest that apoptosis, as assessed by caspase-3 activation, begins in the adherent cells and continues in the floating cells, and that the floating cells represent a relatively pure population of apoptotic MCF-7-C3 cells.
Effector caspase activation occurs in etoposide-treated MCF-7-N1 cells
To determine whether etoposide-induced death of MCF-7 cells involved activation of an additional effector caspase that may function in the absence of caspase-3, lysates of etoposide-treated -N1 and -C3 cells were probed in immunoblots for expression and activation of the effector caspase, caspase-7 using an antibody that recognises both the 35 kDa proform of the enzyme and the p19, active large subunit. As shown in Figure 3, procaspase-7 is constitutively expressed in MCF-7 cells regardless of the expression of caspase-3. Furthermore, in lysates of both -N1 and -C3 cells, the large subunit of active caspase-7 was detectable by 48 h after treatment with etoposide and highly prominent by 72 h (Figure 3). Since caspase activation is often used as a hallmark of apoptosis, the observation that an effector caspase is activated in MCF-7-N1 cells indicates that the etoposide-induced death of N1 cells is likely to be a form of apoptosis, albeit one that lacks classical morphological features and DNA-degradative steps (see below).
Caspase-3 is required for the acquisition of apoptotic morphology and cell-autonomous DNA degradation, but is dispensable for phosphatidylserine exposure
To study further the apoptotic features of the floating MCF-7-C3 and MCF-7-N1 cells, etoposide-treated detached cells were subjected to morphological analysis and were also assessed for their capacity to degrade DNA and to expose phosphatidylserine. As shown in Figure 4a, the morphological differences between caspase-3-positive and -negative floating MCF-7 cells as revealed by DAPI staining were striking. Caspase-3-positive cells displayed the classical nuclear features of apoptosis with condensed and fragmented chromatin whereas the nuclei of caspase-3-negative cells remained diffusely stained. Laddering of DNA into low molecular weight oligonucleosomal fragments was readily demonstrable in lysates of floating MCF-7-C3 cells, but not in -N1-derived lysates (Figure 4b). Similarly, in situ end labelling (ISEL) of free 3′ hydroxy ends of DNA fragments with biotin-conjugated deoxynucleotides was readily demonstrable in floating, etoposide-treated MCF-7-C3 cells, but not in -N1 cells (see Figure 7c).
In stark contrast to these results, flow cytometric analysis of annexin V labelling indicated that phosphatidylserine (PS) exposure by floating cells collected after etoposide treatment was closely comparable in MCF-7-C3 and -N1 populations (Figure 4c), although at early time points the degree of PS exposure was marginally lower in the caspase-3-negative cells as compared to the caspase-3-positives. Thus in the experiment shown in Figure 4c, at 12 h post-etoposide treatment 62% of MCF-7-N1 cells were found to be annexin V-positive as compared to 76% of -C3 cells. Furthermore, a significant proportion of the positive -N1 cells was stained less brightly than the positive -C3 cells (Figure 4c). Differences between the two cell populations were less marked at 24 h, and by 48 h both the proportions of stained cells (∼90%) and the intensities of staining were comparable in -N1 and -C3 cells. Analysis of plasma-membrane integrity by trypan blue exclusion indicated that, for both -N1 and -C3 cells, the majority of the floating MCF-7 cells were similarly permeable at all time points tested. Thus, at 24 h, -N1 cells were 68.9±4.7% (mean±S.E.M.) trypan blue positive and -C3 cells were 72±3.5%; at 48 h, -N1 cells were 70.6±6.4% and -C3 cells were 80.2±8.1% positive; at 72 h. -N1 cells were 75.2±4.7% and -C3 cells were 87.0±1.9% positive. However, as shown in Figure 4d, -N1 floating cells with intact plasma membranes as judged by GFP retention (see panel (I), Figure 4d) were also strongly annexin V-positive (annexinhigh/GFPhigh) at all time points tested (panels (II) – (III), Figure 4d). Similar results were obtained when -C3 cells were analysed in the same way and, furthermore, continued culture of floating cells harvested from etoposide-treated -N1 or -C3 cultures resulted in annexinhigh/GFPhighcells joining the populations of annexinhigh/GFPlow cells (data not shown). These results indicate that PS exposure on MCF-7 cells occurs independently of caspase-3 activation.
Phagocytic clearance of apoptotic MCF-7 cells occurs in the absence of caspase-3
Since MCF-7 cells released from the monolayer following etoposide treatment fail to readhere to plastic or glass (data not shown), such cells were usable as targets in macrophage clearance assays. To determine whether the detached MCF-7 cells were recognised by macrophages, floating -N1 and -C3 cells were collected at various times after etoposide treatment and equivalent numbers of cells were exposed to 7-day-matured monocyte-derived macrophages in a well-established in vitro assay of recognition and engulfment of apoptotic cells by human professional phagocytes. Apoptotic Burkitt lymphoma cells, which have proven utility as targets in these assays,9,10,33 were used to monitor the efficacy of the macrophage preparations to interact with apoptotic cells. As shown in Figure 5, floating MCF-7 cells were capable of interacting with macrophages independently of caspase-3 activation. While both -N1 and -C3 cells collected at 48 h were capable of interacting effectively with macrophages, -C3 cells were generally more effective at this time point (Figure 5a,b). However, this difference was not sustained, and -N1 and -C3 cells collected at 72 h were found to be equally effective in the macrophage interaction assays.
To analyse these interactions in more detail, assays were carried out in the presence of the mAb 61D3, a known inhibitor of the interaction of apoptotic cells with macrophage CD14. As shown in Figure 5b, significant inhibition of the interaction with macrophages of both -N1 and -C3 cells was observed with 61D3. Inclusion of nonblocking CD14 mAbs (such as 63D3, see Devitt et al.)10 in these assays failed to cause inhibition (data not shown). These results suggest that ligands capable of interacting with the CD14-dependent clearance pathway are functional at apoptotic-cell surfaces independently of caspase-3 activation. Furthermore, the partial inhibitory effect of 61D3 in both caspase-3-positive and -negative cases (Figure 5b) suggests that apoptotic cells also acquire the capacity to interact with additional macrophage receptors regardless of caspase-3 activation.
As illustrated in Figure 6a, the macrophage-interacting -N1 and -C3 cells are in each case a mixture of both bound and phagocytosed cells. Further microscopic analyses of macrophages interacting with N1 or C3 cells indicated that the frequency of phagocytic vacuoles was similar for both targets. Thus, as shown in Figure 6b, similar proportions of macrophages interacting with MCF-7 cells collected at 48 or 72 h after etoposide treatment were found to contain phagocytic vacuoles (according to morphological criteria, Figure 6a) regardless of the caspase-3 content. Notably, MCF-7-N1 cells became positive for degraded DNA (as evidenced by ISEL) following interaction with macrophages (Figure 7a,b). DNA degradation was most likely effected by DNases present in the phagocytic vacuoles as described in other systems35 and provides further evidence that caspase-3-deficient cells are phagocytosed. Quantitative analysis of macrophages exposed to etoposide-treated MCF-7 cells demonstrated no difference between those interacting with caspase-3-positive and -negative cells (Figure 7a). These results are striking, given the absence of ISEL in free-floating MCF-7-N1 cells (Figure 7c, panel III). By contrast, ISEL was readily apparent in free apoptotic MCF-7-C3 cells (Figure 7c, panel IV) and was only demonstrable in MCF-7-N1 cells after DNase I treatment (Figure 7c, panel II). Importantly, there was no evidence of macrophage death induced by MCF-7-cell co-culture that could have been responsible for the positive ISEL end point in the macrophage cultures. Taken together, these results strongly argue that caspase-3-activation fails to affect binding or phagocytosis of MCF-7 cells differentially.
MCF-7 cells dying via caspase-3-dependent or -independent mechanisms fail to elicit proinflammatory cytokine release by macrophages regardless of caspase-3 activation
Since apoptotic cells are known to suppress proinflammatory cytokine release by macrophages, experiments were carried out in order to determine whether this property was shared by MCF-7 cells undergoing caspase-3-dependent or -independent death. To this end, etoposide-treated MCF-7 cells were tested for their ability to affect LPS-induced secretion of the proinflammatory cytokine, TNF-α from 7-day monocyte-derived macrophages. As shown in Figure 8, TNF-α release by LPS-treated macrophages was markedly reduced to similar levels by etoposide-treated, floating MCF-7-N1 and -C3 cells. Basal levels of TNF-α release were also inhibited by etoposide-treated MCF-7 cells (Figure 8). In each case, macrophage viability remained unaffected by the presence of MCF-7 cells. These results show that caspase-3 is dispensable for the anti-inflammatory effects of dying or dead cells on the macrophage populations that can engulf them.
Discussion
It is now widely accepted that caspase-3 acts in response to diverse stimuli of apoptosis in a wide variety of cell types as an effector or ‘executioner’ caspase,26 which gives rise to several cellular hallmarks of apoptosis.28,29,36 Using caspase-3-defective MCF-7 cells, we confirm here that caspase-3 is responsible for key stereotypical features of apoptosis in human cells. Thus, in the absence of caspase-3, MCF-7 cells responding to the genotoxic stimulus, etoposide die without displaying the classical morphological features of apoptosis and, at the same time, fail to develop the well-established biochemical hallmarks of DNA degradation into low-molecular-weight fragments. However, in MCF-7 cells that produce caspase-3, the same genotoxic stimulus causes caspase-3 activation and engenders both the classical morphological features of apoptosis and typical mode of oligonucleosomal DNA degradation.
The ultimate fate of apoptotic cells in tissues is their non-phlogistic engulfment by phagocytes. Using an in vitro system that provides a powerful human model for such clearance by macrophages, we demonstrate for the first time that constitutive absence of caspase-3 fails to alter significantly the capacity of dying and dead cells to be phagocytosed. CD14 is one of several macrophage receptors involved in apoptotic-cell clearance10 and the results presented here further indicate that etoposide-induced MCF-7 cells can be cleared by macrophages both by CD14-dependent and -independent mechanisms regardless of the activation of caspase-3. Importantly, the phagocytosis of both caspase-3-deficient and caspase-3-replete cells is anti-inflammatory in nature as demonstrated by the equal abilities of caspase-3-positive and -negative cells to suppress inflammatory cytokine production by macrophages. While the present study was limited to cell populations containing mainly late-stage apoptotic cells, previous studies have suggested that such cells, including those that have lost plasma membrane integrity can retain anti-inflammatory characteristics.37 It may be predicted that the anti-inflammatory effects of the dying MCF-7 cells are mediated via an autocrine mechanism involving macrophage TGF-β1 release as established previously for the phagocytosis of apoptotic, caspase-3-positive leukocytes.3
What characteristics of apoptotic cells permit or support their interaction with phagocytes thereby allowing their final engulfment and safe degradation? Redistribution of phospholipids occurs during apoptosis and it is well established that the anionic phospholipid phosphatidylserine (PS), a component of the inner leaflet of the plasma membranes of viable cells, becomes exposed during apoptosis and participates in the clearance process as a new component of the external plasma-membrane leaflet.4,6 Recent elegant work has shown that PS interacts with a novel macrophage PS-receptor.11 Such interactions may comprise a necessary prerequisite of the process of engulfment and may also lead to the initiation of intracellular anti-inflammatory signals.11 Our results show that PS is exposed on apoptotic MCF-7 cells in the absence of caspase-3, confirming observations of apoptotic thymocytes36 and of embryonic fibroblasts29 from caspase-3-deficient mice. While PS exposure on apoptotic cells is therefore caspase-3-independent, caspase involvement in this process has not been demonstrated directly and it is not clear how caspase activity could contribute to PS exposure, although it has been proposed that possible tethering of PS in the inner membrane leaflet through association with cytoskeletal elements such as fodrin may be lost in apoptosis as a result of caspase-mediated cleavage of fodrin.38 Cleavage of fodrin, however, appears to be strictly caspase-3-dependent in vivo,36,39 suggesting that if caspase-dependent inhibition of PS-tethering contributes to exposure of PS at the cell surface, it is unlikely to be through fodrin cleavage. The effects of caspases on other mechanisms that drive PS exposure during apoptosis, such as lipid scramblase activity,40 have not been investigated.
It is probable that PS exposure, while it may be necessary, is not sufficient for apoptotic-cell recognition and engulfment by macrophages. Persuasive arguments have been made for a two-step process involving an initial tethering of the apoptotic cell to the phagocyte, followed by a PS-R-dependent engulfment phase.22 Apart from qualitative changes in ICAM-3 that occur at the surface of apoptotic leukocytes,9 little definitive information is yet available as to the additional cell-surface changes that function in apoptotic-cell clearance. The most popular view to date is that apoptotic cells display ‘eat-me’ signals or apoptotic cell-associated molecular patterns that allow the innate immune system to discriminate the plasma membrane of the apoptotic cell from that of its viable counterpart.41 An alternative view is that viable cells display ‘repulsive’ signals for phagocytes that are lost as a consequence of apoptosis.42 In either case, the present studies suggest strongly that the plasma-membrane changes that are sufficient for phagocytic clearance of apoptotic cells occur independently of caspase-3 activation. Since it is now becoming clear that, in addition to PS exposure, further changes at the surface of dying cells are required for phagocytic clearance by macrophages,43 the present results indicate that caspase-3 is dispensable for the generation of such changes. Intriguingly, however, while annexin V binding to -N1 and -C3 floating cells at 48 and 72 h were comparable, -N1 cells at 48 h interacted less effectively with macrophages than -C3 cells at the same time point. It is tempting to speculate that the additional molecular changes (or a subset of such) that are required to facilitate the interaction of apoptotic cells with macrophages are acquired more quickly when caspase-3 is active. Further work will be required to investigate this possibility.
The detailed biochemical routes to the membrane alterations that confer the capacity for clearance on an apoptotic cell remain to be established. Although our studies indicate that such alterations proceed in the absence of caspase-3, they do not address the question of overall caspase dependence. Caspase-7 is closely homologous to caspase-3 and, like caspase-3, is an acknowledged effector caspase in view of its short prodomain. In contrast to a recent report,44 we found caspase-7 to be readily activated in MCF-7 cells following etoposide treatment regardless of caspase-3 activation. Some of us have previously reported caspase-7 activation in MCF-7 cells treated with TRAIL.30 Although apoptosis may occur in the absence of caspase activation (see below), activation of caspase-7 helps to define death as apoptosis in MCF-7 cells lacking caspase-3. Other criteria such as PS exposure, cytoplasmic condensation and membrane blebbing45,46enhance this definition. The use of polycaspase peptide inhibitors may help to answer the question of caspase dependence of apoptotic-cell clearance. The broad-spectrum caspase inhibitor z-VAD-fmk has been shown to inhibit multiple features of apoptosis in leukocyte lines, including the capacity to interact with phagocytes, suggesting that the latter is caspase-dependent.46 In the same cells, however, antimycin A and oligomycin have been used to dissociate caspase activation from PS exposure and phagocytosis of apoptotic cells by murine macrophages46 indicating that the clearance phenotype is not inextricably linked to other aspects of the apoptosis programme including caspase activation. A major problem with addressing the question of the caspase-dependence of apoptotic-cell clearance using inhibitors such as z-VAD-fmk is that such approaches fail to differentiate between the caspase-dependence of the initiation of apoptosis and the caspase-dependence of the downstream pathways that are ultimately responsible for altering the apoptotic-cell surface. In the present model, MCF-7 cells were induced to undergo apoptosis through genotoxic damage, a mitochondrial pathway of apoptosis that, in light of previous studies that order the caspase activation events following release of cytochrome c from mitochondria,47 would be predicted to generate active effector caspase-3 and -7 consequent to the activation of caspase-9. It may be of interest to compare the present results with the consequences for phagocytic clearance of initiating apoptosis through a nonmitochondrial pathway, such as death-receptor ligation. In this context, it is interesting to note that Bcl-2 can protect both lymphoid cells and neutrophils from morphologically identifiable apoptosis.48,49 In the case of neutrophils, but not lymphocytes, Bcl-2 fails to prevent phagocytic clearance.49 These results indicate that the biochemical pathways affected by Bcl-2 that appear to delay apoptosis in neutrophils can be uncoupled from those that endow these cells with the capacity to be phagocytosed. Since Bcl-2 protects cells at the level of mitochondria, it is tempting to speculate, particularly in view of the present findings, that the signalling pathways that alter the cell surface following the initiation of apoptosis lie upstream of the mitochondrial phase, at least in some cell types. Within the present cell model, judicious use of the peptide inhibitor DEVD-fmk may possibly provide an opportunity to inhibit caspase-7 and thereby address the question of effector caspase involvement in apoptotic-cell clearance. However, caspase-7 activation may provide a mechanism through which apoptotic MCF-7 cells lose adhesion contacts in the absence of caspase-3 since caspase-7 is most effective in cleaving focal adhesion kinase.50 In this context, we have found that the polycaspase inhibitor, z-VAD-fmk and the caspase-3 and -7 inhibitor z-DEVD-fmk can inhibit loss of adhesion of etoposide-treated MCF-7 cells (data not shown).
Evidence obtained from several cell systems has indicated that programmed death of multiple lineages of cells can occur via caspase-independent routes,51,57 but the efficiency with which such cells are phagocytosed has not been investigated. Loss of function of aged platelets appears to be due to a process that closely resembles apoptosis but which is caspase-independent.58 Significantly, the phagocytic clearance of such intact effete platelets proceeds normally suggesting that caspases may be dispensable for the apoptosis-driven cell surface alterations that are required for efficient phagocytosis of apoptotic cells. In view of these findings, further investigations of the phagocytosis of cells dying through caspase-independent routes are warranted.
It has been shown in other cell types, notably hepatocytes, that deficiency in caspase-3 can cause compensatory activation of alternative caspases (−2, −6 and −7) in the initiation and execution of apoptosis.59 This, however, may be a tissue-specific phenomenon as compensatory caspase activation was not observed in thymocytes.59 Compensatory caspase activation was not investigated directly in the present studies, but it is clear that, regardless of whether compensation occurs in MCF-7 cells receiving a pro-apoptosis stimulus, certain features of the apoptosis programme – morphological and DNA-degradative changes – are not restored. By contrast, other features – including PS exposure and the capacity to be phagocytosed non-phlogistically – proceed virtually normally. Therefore, even though caspase-7 may appear structurally and, potentially, functionally similar to caspase-3 (and, when overexpressed in active form in MCF-7 cells can even enhance apoptosis almost to the levels achieved by caspase-3 60), caspase-7 activity at physiological levels in MCF-7 cells is unable to substitute for the absence of caspase-3. This may reflect the differential subcellular compartmentalisation of caspase–3 and –7.61 It is noteworthy that detailed comparison of the activities of effector caspases towards a range of key substrates cleaved during apoptosis has suggested that the so-called effector caspases –6 and –7 do little to contribute to the degradation of apoptotic cells beyond the activity of caspase-3.62 From the results of the present studies, we conclude that the biochemical pathways that lead to (at least some of) the hallmarks of apoptosis are nonredundant, run in parallel and can be uncoupled from one another.
The finding that the capacity to be phagocytosed can be generated in cells lacking caspase-3 suggests a mechanism by which cells lacking the typical morphological features of apoptosis can come to lie in phagocytic vacuoles. Thus, cells that have engaged the apoptosis programme may be phagocytosed as a result of the biochemical pathways that generate the capacity to be cleared being activated separately from, and prior to, caspase-3. Significantly, phagocytosed cells that appear morphologically viable have been shown to display externalised PS.63 More importantly, the phagocytosis of apoptotic cells without caspase-3 activation has important implications for therapeutic strategies aimed at inhibiting caspase effector functions (see Nicholson 26). The present study is limited to an in vitro model in which the majority of the cells analysed in macrophage assays were at a late stage of the apoptotic process. It remains possible that caspase-3 activation may be important for early-stage engulfment of apoptotic cells, although the arguments above supported by the observations of Van den Eijnde et al.63 suggest otherwise. Clearly, it will be important to determine whether cells rescued by caspase inhibition survive long-term in vivo or whether they remain ultimately susceptible to phagocytic clearance mechanisms. In addition, alteration of the mechanisms by which such cells are cleared through abolition of certain pathways in the apoptosis programme may have consequences for immune responses as has been shown in other systems.64 Finally, of particular relevance to the present study is the recent report that caspase-3 fails to influence the response of MCF-7 tumour xenografts to photodynamic therapy.65
Chronological ordering of the key molecular events in apoptosis is confounded by the complexities of the programme, including multiple pathways of initiation, the involvement of molecular cascades with amplification loops, subcellular compartmentalisation of effector components and variation according to cell lineage. For the moment, we can conclude that a dying cell's capacity to be phagocytosed by a macrophage can be acquired in the absence of the prototypic effector caspase, caspase-3. Defining the mechanisms that underlie the surface changes of apoptotic cells that are necessary and sufficient for phagocytic clearance and relating them temporally to other aspects of the apoptotic programme remains a significant challenge.
Materials and Methods
Cell lines and transfection
MCF-7 cells and Mutu I cells were grown in RPMI 1640 medium containing 2 mM L-glutamine supplemented with 10% fetal calf serum (FCS) or Serum Supreme (BioWhittaker, Wokingham, UK) and 100 IU ml−1 penicillin and 100 μg ml−1 streptomycin) (complete medium). MCF-7 transfectants were derived by electroporation using pEGFP-N1 (Clontech, Palo Alto, CA, USA) or pEGFP-C3.30 The latter was derived by cloning full-length caspase-3 cDNA into the pEGFP-N1 expression vector at the BamH1 and Xho1 sites such that the green fluorescent protein (GFP) was located at the carboxy-terminus of the expressed caspase. This construct has been shown previously to be capable of generating active caspase-3 protease (DEVDase) activity in MCF-7 cells.30 Cells were subsequently selected both by neomycin resistance and by fluorescence-activated cell sorting according to GFP expression.
Induction of cell death
Adherent cells were trypsinised, collected into complete medium, seeded into multiwell plates or Petri dishes and incubated at 37°C overnight to allow readherence and resumption of logarithmic growth. Etoposide (Sigma, Poole, UK, 100 μM) was added to cells when at 40–50% confluency. Mutu I BL cells were induced into apoptosis by the addition of ionomycin (Calbiochem, Nottingham, UK, 1 μg ml−1) followed by incubation at 37°C for 18 h.
Measurement of cell detachment from monolayers
Drug-treated floating cells were resuspended in complete medium and counted using a Neubauer haemocytometer. The remaining adherent cells were collected by trypsinisation, resuspended in complete medium and counted. The number of floating cells was expressed as a percentage of the total population. Plasma-membrane integrity was assessed by trypan blue exclusion.
Determination of cellular morphology
Drug-treated floating MCF-7 cells were collected, washed twice in 1% bovine serum albumin (BSA) in PBS and fixed in 1% formaldehyde in 1% BSA in PBS and stored for up to a week at 4°C. Immediately prior to observation, fixed cells were stained with 4,6-diamidino-2-phenylindole (DAPI, Sigma, 2.5 μg ml−1) and observed using a Zeiss Axioskop 2 fluorescence microscope (Carl Zeiss Ltd., Welwyn Garden City, UK).
Measurement of DNA degradation
In situ end labelling (ISEL). Floating MCF-7 cells were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.2) and resuspended in 80% ethanol for storage. Staining was performed using an ISEL kit (TdT FragEL DNA fragmentation detection kit, Oncogene Research Products, CN Biosciences, Nottingham, UK) according to the manufacturer's instructions with phycoerythrin-conjugated streptavidin (Vector Laboratories, Burlingame, CA, USA) as the final read-out step. Cells were analysed immediately on the Coulter XL flow cytometer (Beckman Coulter, Fullerton, CA, USA). In some experiments, ISEL was carried out on macrophage monolayers following interaction with apoptotic cells. In this case, the final read-out step was Texas-Red-conjugated streptavidin (Vector Laboratories) and cells were analysed under the fluorescence microscope.
DNA laddering
The method was carried out as described,31 and applied to floating and adherent cells, collected separately. Samples were subjected to electro-phoresis on 2% agarose gels containing 0.5 μg ml−1 ethidium bromide.
Annexin V staining for phosphatidylserine (PS) exposure
Annexin V staining of MCF-7 transfectants, in combination with GFP fluorescence, was assessed by flow cytometry. Loss of GFP fluorescence was used as a measure of plasma-membrane disruption since the standard indicator, propidium iodide, was found to be incorporated into viable MCF-7 cells. Floating MCF-7 cells (1–2 × 105) were collected, washed twice in binding buffer (10 mM HEPES pH 7.4, 140 mM NaCl, 2.5 mM CaCl2) and incubated at 4°C with biotin-conjugated annexin V (Alexis Corp., San Diego, CA, USA). Cells were washed twice in binding buffer then incubated at 4°C with Quantum Red-conjugated streptavidin (Sigma). Duplicate samples were prepared in the absence of annexin V to monitor background fluorescence. Samples were analysed on the Coulter XL flow cytometer. Plasma-membrane permeability was assessed simul-taneously by monitoring GFP fluorescence levels, which were found to correlate directly with trypan blue exclusion as assessed microscopically.
SDS-PAGE and Western blotting
Control adherent (no etoposide) or etoposide-treated adherent and floating cells were collected separately, washed twice in PBS and the dry pellet stored at –80°C. Cells were subsequently suspended in PBS and sonicated. For caspase-7 analyses, etoposide-treated cells were collected by scraping adherent cells into a suspension containing floating cells. The remaining procedure was carried out as previously described.30,32 Blots were probed with mouse anti-caspase-3 mAb (Santa Cruz Biotechnology Inc., CA, USA), and rabbit polyclonal anti-caspase-7. Visualisation was by ECL (Amersham Pharmacia).
Macrophage interaction assays
These were carried out using 7-day human monocyte-derived macrophages isolated as described.10,33 Floating cells of etoposide-treated MCF-7 cell populations were washed in serum-free RPMI 1640, diluted in RPMI containing 0.2% BSA such that all samples contained the same concentration of cells (7.5 × 105 to 1.5 × 106 cells ml−1). Macrophages on glass slides were incubated with MCF-7 or ionomycin-treated Mutu I Burkitt lymphoma cells at 37°C in 5% CO2 for 1 h. Unbound cells were removed by dipping slides in cold PBS and cells fixed in methanol for 10 min. In some cases, anti-CD14 mAbs were added as described.10 Cells were finally stained in Jenner–Giemsa and the proportions of free and target-cell bound macrophages were determined by light microscopy. In all, 200 macrophages were scored per well with duplicate wells per sample. Statistical analysis of the assays was performed using the Student's t-test for which P<0.05 was significant.
Cytokine production
7-day human monocyte-derived macrophages were cultured in 24-well trays either alone or in the presence of LPS (E.coli O111:B4, Sigma), 5 ng/ml and/or apoptotic MCF-7 cells (5 × 105 cells per well – 48 h etoposide-treated, non-adherent cells) for 18 h. Cell-free supernatants were collected and assayed for TNF-α by ELISA using matched-pair anti-TNF-α mAbs (R&D Systems Inc., Minneapolis, MN, USA).
Abbreviations
- PS:
-
phosphatidylserine
- DAPI:
-
4,6-diamidino-2-phenylindole
- GFP:
-
green fluorescent protein
- ISEL:
-
In situ end labelling
- PS-R:
-
PS-receptor
- ICAD:
-
inhibitor of caspase-activated DNase
References
Savill J and Fadok V (2000) Corpse clearance defines the meaning of cell death. Nature 407: 784–788
Fadok VA, Bratton DL and Henson PM (2001) Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J. Clin. Invest. 108: 957–962
Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY and Henson PM (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J. Clin. Invest. 101: 890–898
Fadok VA, Voelker DR, Campbell PA, Cohen U, Bratton DL and Henson PM (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148: 2207–2216
Verhoven B, Schlegel RA and Williamson P (1995) Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J. Exp. Med. 182: 1597–1601
Fadok VA, de Cathelineau A, Daleke DL, Henson PM and Bratton DL (2001) Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts. J. Biol. Chem. 276: 1071–1077
Duvall E, Wyllie AH and Morris RG (1985) Macrophage recognition of cells undergoing programmed cell death (apoptosis). Immunology 56: 351–358
Dini L, Autuori F, Lentini A, Oliverio S and Piacentini M (1992) The clearance of apoptotic cells in the liver is mediated by the asialoglycoprotein receptor. FEBS Lett. 296: 174–178
Moffatt OD, Devitt A, Bell ED, Simmons DL and Gregory CD (1999) Macrophage recognition of ICAM-3 on apoptotic leukocytes. J. Immunol. 162: 6800–6810
Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL and Gregory CD (1998) Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 392: 505–509
Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RAB and Henson PM (2000) A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405: 85–90
Savill J, Dransfield I, Hogg N and Haslett C (1990) Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 343: 170–173
Savill J, Hogg N, Ren Y and Haslett C (1992) Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J. Clin. Invest. 90: 1513–1522
Ren Y, Silverstein RL, Allen J and Savill J (1995) CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J. Exp. Med. 181: 1857–1862
Platt N, Suzuki H, Kurihara Y, Kodama T and Gordon S (1996) Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Proc. Natl. Acad. Sci. USA 93: 12456–12460
Luciani M-F and Chimini G (1996) The ATP binding cassette transporter ABC1, is required for the engulfment of corpses generated by apoptotic cell death. EMBO J. 15: 226–235
Hamon Y, Broccardo C, Chambenoit O, Luciani MF, Toti F, Chaslin S, Freyssinet JM, Devaux PF, McNeish J, Marguet D and Chimini G (2000) ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat. Cell Biol. 2: 399–406
Scott RS, McMahon EJ, Pop SM, Reap EA, Caricchio R, Cohen PL, Earp HS and Matsushima GK (2001) Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411: 207–211
Ogden CA, deCathelineau A, Hoffmann PR, Bratton D, Ghebrehiwet B, Fadok VA and Henson PM (2001) C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194: 781–795
Botto M, DellAgnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP and Walport MJ (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Gene. 19: 56–59
Gershov D, Kim S, Brot N and Elkon KB (2000) C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J. Exp. Med. 192: 1353–1363
Hoffmann PR, deCathelineau AM, Ogden CA, Leverrier Y, Bratton DL, Daleke DL, Ridley AJ, Fadok VA and Henson PM (2001) Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J. Cell Biol. 155: 649–659
Reddien PW, Cameron S and Horvitz HR (2001) Phagocytosis promotes programmed cell death in C. elegans. Nature 412: 198–202
Hoeppner DJ, Hengartner MO and Schnabel R (2001) Engulfment genes cooperate with ced-3 to promote cell death in Caenorhabditis elegans. Nature 412: 202–206
Cohen GM (1997) Caspases: the executioners of apoptosis. Biochem. J. 326: 1–16
Nicholson DW (1999) Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 6: 1028–1042
Wyllie AH, Kerr JFR and Currie AR (1980) Cell death: the significance of apoptosis. Int. Rev. Cytol. 68: 251–305
Janicke RU, Sprengart ML, Wati MR and Porter AG (1998) Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273: 9357–9360
Woo M, Hakem R, Soengas MS, Duncan GS, Shahinian A, Kagi D, Hakem A, McCurrach M, Khoo W, Kaufman SA, Senaldi G, Howard T, Lowe SW and Mak TW (1998) Essential contribution of caspase 3 CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 12: 806–819
MacFarlane M, Merrison W, Dinsdale D and Cohen GM (2000) Active caspases and cleaved cytokeratins are sequestered into cytoplasmic inclusions in TRAIL-induced apoptosis. J. Cell Biol. 148: 1239–1254
Gregory CD, Dive C, Henderson S, Smith CA, Williams GT, Gordon J and Rickinson AB (1991) Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosis. Nature 349: 612–614
MacFarlane M, Cain K, Sun XM, Alnemri ES and Cohen GM (1997) Processing/activation of at least four interleukin-1 beta converting enzyme-like proteases occurs during the execution phase of apoptosis in human monocytic tumor cells. J. Cell Biol. 137: 469–479
Flora PK and Gregory CD (1994) Recognition of apoptotic cells by human macrophages – inhibition by a monocyte/macrophage-specific monoclonal antibody. Eur. J. Immunol. 24: 2625–2632
Li F, Srinivasan A, Wang Y, Armstrong RC, Tomaselli KJ and Fritz LC (1997) Cell-specific induction of apoptosis by microinjection of cytochrome c - Bcl-x(L) has activity independent of cytochrome c release. J. Biol. Chem. 272: 30299–30305
McIlroy D, Tanaka M, Sakahira H, Fukuyama H, Suzuki M, Yamamura K, Ohsawa Y, Uchiyama Y and Nagata S (2000) An auxiliary mode of apoptotic DNA fragmentation provided by phagocytes. Genes Dev. 14: 549–558
Zheng TS, Schlosser SF, Dao T, Hingorani R, Crispe IN, Boyer JL and Flavell RA (1998) Caspase-3 controls both cytoplasmic and nuclear events associated with Fas-mediated apoptosis in vivo. Proc. Natl. Acad. Sci. USA 95: 13618–13623
Fadok VA, Bratton DL, Guthrie L and Henson PM (2001) Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: role of proteases. J. Immunol. 166: 6847–6854
Fadok VA, Bratton DL, Frasch SC, Warner ML and Henson PM (1998) The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ. 5: 551–562
Janicke RU, Ng P, Sprengart ML and Porter AG (1998) Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J. Biol. Chem. 273: 15540–15545
Bratton DL, Fadok VA, Richter DA, Kailey JM, Guthrie LA and Henson PM (1997) Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase. J. Biol. Chem. 272: 26159–26165
Gregory CD (2000) CD14-dependent clearance of apoptotic cells: relevance to the immune system. Curr. Opin. Immunol. 12: 27–34
Brown S, Heinisch I, Ross E, Shaw K, Buckley CD and Savill J (2002) Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment. Nature 418: 200–203
Devitt A, Pierce S, Oldreive C, Shingler WH and Gregory CD (2002) CD14-dependent clearance of apoptotic cells by human macrophages: the role of phosphatidylserine. Submitted
Yang XH, Sladek TL, Liu XS, Butler BR, Froelich CJ and Thor AD (2001) Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. Cancer Res. 61: 348–354
Tewari M and Dixit VM (1995) Fas-induced and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene-product. J. Biol. Chem. 270: 3255–3260
Zhuang JG, Ren Y, Snowden RT, Zhu HJ, Gogvadze V, Savill JS and Cohen GM (1998) Dissociation of phagocyte recognition of cells undergoing apoptosis from other features of the apoptotic program. J. Biol. Chem. 273: 15628–15632
Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang HG, Reed JC, Nicholson DW, Alnemri ES, Green DR and Martin SJ (1999) Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9- dependent manner. J. Cell Biol. 144: 281–292
Flora PK, Devitt A, Johnson GD, Milner AE and Gregory CD (1996) Bcl-2 delays macrophage engulfment of human B cells induced to undergo apoptosis. Eur. J. Immunol. 26: 2243–2247
Lagasse E and Weissman IL (1994) Bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J. Exp. Med. 179: 1047–1052
Wen LP, Fahrni JA, Troie S, Guan JL, Orth K and Rosen GD (1997) Cleavage of focal adhesion kinase by caspases during apoptosis. J. Biol. Chem. 272: 26056–26061
Xiang JL, Chao DT and Korsmeyer SJ (1996) BAX-induced cell death may not require interleukin 1 beta- converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA 93: 14559–14563
McCarthy NJ, Whyte MKB, Gilbert CS and Evan GI (1997) Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol. 136: 215–227
Kawahara A, Ohsawa Y, Matsumura H, Uchiyama Y and Nagata S (1998) Caspase-independent cell killing by Fas-associated protein with death domain. J. Cell Biol. 143: 1353–1360
Quignon F, De Bels F, Koken M, Feunteun J, Ameisen JC and de The H (1998) PML induces a novel caspase-independent death process. Nat. Genet. 20: 259–265
Monney L, Otter I, Olivier R, Ozer HL, Haas AL, Omura S and Borner C (1998) Defects in the ubiquitin pathway induce caspase-independent apoptosis blocked by Bcl-2. J. Biol. Chem. 273: 6121–6131
Bojes HK, Feng X, Kehrer JP and Cohen GM (1999) Apoptosis in hematopoietic cells (FL5.12) caused by interleukin-3 withdrawal: relationship to caspase activity and the loss of glutathione. Cell Death Differ. 6: 61–70
Doerfler P, Forbush KA and Perlmutter RM (2000) Caspase enzyme activity is not essential for apoptosis during thymocyte development. J. Immunol. 164:4071–4079
Brown SB, Clarke MCH, Magowan L, Sanderson H and Savill J (2000) Constitutive death of platelets leading to scavenger receptor- mediated phagocytosis - a caspase-independent cell clearance program. J. Biol. Chem. 275: 5987–5996
Zheng TS, Hunot S, Kuida K, Momoi T, Srinivasan A, Nicholson DW, Lazebnik Y and Flavell RA (2000) Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation. Nat. Med. 6: 1241–1247
Duan HJ, Chinnaiyan AM, Hudson PL, Wing JP, He WW and Dixit VM (1996) ICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein ced-3 is activated during fas- and tumor necrosis factor-induced apoptosis. J. Biol. Chem. 271: 1621–1625
Chandler JM, Cohen GM and MacFarlane M (1998) Different subcellular distribution of caspase-3 and caspase-7 following Fas-induced apoptosis in mouse liver. J. Biol. Chem. 273: 10815–10818
Slee EA, Adrain C and Martin SJ (2001) Executioner caspase-3,-6, and-7 perform distinct, non-redundant roles during the demolition phase of apoptosis. Journal of Biol. Chem. 276: 7320–7326
Van den Eijnde SM, Boshart L, Reutelingsperger CPM, De Zeeuw CI and Vermeij-Keers C (1997) Phosphatidylserine plasma membrane asymmetry in vivo: a pancellular phenomenon which alters during apoptosis. Cell Death Differ. 4: 311–316
Sauter B, Albert ML, Francisco L, Larsson M, Somersan S and Bhardwaj N (2000) Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191: 423–433
Whitacre CM, Satoh TH, Xue LY, Gordon NH and Oleinick NL (2002) Photodynamic therapy of human breast cancer xenografts lacking caspase-3. Cancer Lett. 179: 43–49
Acknowledgements
This work was supported by the Medical Research Council (UK). CT was the recipient of a studentship from the Cancer Research Campaign (UK).
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by M Piacentini
Rights and permissions
About this article
Cite this article
Turner, C., Devitt, A., Parker, K. et al. Macrophage-mediated clearance of cells undergoing caspase-3-independent death. Cell Death Differ 10, 302–312 (2003). https://doi.org/10.1038/sj.cdd.4401170
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4401170
Keywords
This article is cited by
-
Loss of Cdk5 in breast cancer cells promotes ROS-mediated cell death through dysregulation of the mitochondrial permeability transition pore
Oncogene (2018)
-
Serine proteases mediate apoptosis-like cell death and phagocytosis under caspase-inhibiting conditions
Cell Death & Differentiation (2003)
-
CD14-dependent clearance of apoptotic cells by human macrophages: the role of phosphatidylserine
Cell Death & Differentiation (2003)